Get ready for flu season...or not...
US drugmaker Chiron is facing a significant shortfall in the volume of influenza vaccine it will be able to ship to markets outside the US as a result of sterility problems uncovered at another of its manufacturing plants, reports Phil Taylor.
Link from in-pharma-tech.com
Monday, July 18, 2005
Second Chiron plant has sterility problems
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment